Alkem Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Alkem Laboratories Ltd. from all sources in a single place.

Load latest

Alkem Laboratories Ltd.

29 May 2025

4870.50

0.56%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

The BOD approved the appointment of Mr. Ranjal Shenoy and Ms. Neela Bhattercherjee as an Independent Director for a term of 5 consecutive years wef 13th July, 2025.

pdf

Alkem Laboratories Ltd.

29 May 2025

4870.50

0.56%

Result

Alkem Laboratories Ltd - 539523 - Results- Please Find Enclosed Herewith The Outcome Of Board Meeting …

BSE India

Please find enclosed Audited Financial Results along with Auditors Report for FY ended 31st march 25

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	3289.71	3467.27	3023.99	-5.1%	8.8%
Operating Profit Qtr	391.29	759.39	401.98	-48.5%	-2.7%
Net Profit Qtr	305.86	625.82	293.56	-51.1%	4.2%
Earning Per Share Adjusted latest Qtr	25.58	52.34	24.55	-51.1%	4.2%

* Consolidated data

Detailed Results

Alkem Laboratories Ltd.

29 May 2025

4870.50

0.56%

Board Meeting

Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of BM

BSE India

Please find enclosed herewith the Outcome of Board Meeting dated 29th May, 2025. The meeting of the Board of Directors of the Company commenced at 11.25 a.m. and concluded at 13.45 p.m. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

27 May 2025

4870.50

0.56%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meeting scheduled to be held on 03rd June, 2025

pdf

Alkem Laboratories Ltd.

19 May 2025

4870.50

0.56%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY25 and FY25 financial results will be held on Thursday, 29th May, 2025 at 04.30 p.m. Please find attached herewith the conference call details.

pdf

Alkem Laboratories Ltd.

16 May 2025

4870.50

0.56%

Alkem reports cyber security incident at Enzene's US subsidiary

Business Line

The incident resulted in a fraudulent transfer of funds

BOB Capital Markets Ltd. released a Sell report for Alkem Laboratories Ltd. with a price target of 4527.0 on 30 May, 2025.

Alkem Laboratories Ltd.

16 May 2025

4870.50

0.56%

Board Meeting

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of …

BSE India

Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve (i) the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2025; and (ii) to consider and recommend Final Dividend, if any, for financial year ended 31st March, 2025. Kindly take note of the same.

pdf

Alkem Laboratories Ltd.

15 May 2025

4870.50

0.56%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 (LODR) With Respect To A Cyber …

BSE India

Enclosed herewith is the disclosure with respect to a cyber security incident involving a US subsidiary of Enzene Biosciences Limited, a subsidiary of the Company.

pdf